RxDoctor Payments Data

Meghan Webb, MD

Family Medicine · Philadelphia, MSNPI 1164983151

Payments from drug & device makers

$3,238in general payments, 2019–2025

Across 191 payments — averaging $16.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$983
  • AbbVie$425
  • Lilly USA, LLC$408
  • Bayer$280
  • GSK$276
  • Amgen$256
  • plus $611 from 12 others

What the payments were for

  • Food & beverage$3,238100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,238 in reported general payments places this provider in the 75th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$6,868
Medicare patients
126
Services billed
319

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide77$77,838
FarxigaDapagliflozin Propanediol37$38,503
MounjaroTirzepatide22$34,549
JardianceEmpagliflozin38$29,475
EliquisApixaban27$22,954
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$13,033
MyrbetriqMirabegron16$10,177
KerendiaFinerenone11$9,438
JanuviaSitagliptin Phosphate11$9,160
Trijardy XrEmpaglifloz/Linaglip/Metformin11$6,459
SynthroidLevothyroxine Sodium35$2,872
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog13$1,839
Rosuvastatin Calcium176$1,332
Ezetimibe33$1,258
Gabapentin131$1,223

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$60$77,83877 claims
AstraZenecaFarxiga$983$38,50337 claims
Boehringer IngelheimJardiance, Trijardy Xr$53$35,93349 claims
Lilly USA, LLCMounjaro$408$34,54922 claims
PfizerEliquis$91$22,95427 claims
GSKTrelegy Ellipta$276$13,03320 claims
BayerKerendia$280$9,43811 claims
AbbVieSynthroid$425$2,87235 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 971 family medicine providers in Mississippi.

Other family medicine in Philadelphia

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →